Clinical trials

  • Methoxyflurane 99.9% for Acute Myocardial Infarction
  • GEN3018 for Relapsed or refractory acute myeloid leukemia | High-risk myelodysplastic syndrome
  • UPADACITINIB for Atopic dermatitis
  • MIRIKIZUMAB for Crohn's disease
  • LAD603 for Alopecia areata
  • N-[2-(3-CYANO-5-FLUOROPHENYL)-2-METHYL-1-OXOPROPYL]-BETA-ALANYL-L-ALPHA-GLUTAMYLGLYCYL-L-THREONYL-L-PHENYLALANYL-L-THREONYL-L-SERYL-L-ALPHA-ASPARTYL-L-TYROSYL-L-SERYL-L-ISOLEUCYL-2-METHYLALANYL-L-LEUCYL-L-ALPHA-ASPARTYL-L-LYSYL-L-ISOLEUCYL-L-ALANYL-L-GLUTAMINYL-N6-[N-(19-CARBOXY-1-OXONONADECYL)-L-GAMMA-GLUTAMYL-2-[2-(2-AMINOETHOXY)ETHOXY]ACETYL-2-[2-(2-AMINOETHOXY)ETHOXY]ACETYL]-L-LYSYL-L-ALANYL-L-PHENYLALANYL-L-VALYL-L-GLUTAMINYL-L-TRYPTOPHYL-L-LEUCYL-L-ISOLEUCYL-L-ALANYLGLYCYLGLYCYL-L-PROLYL-L-SERYL-L-SERYLGLYCYL-L-ALANYL-L-PROLYL-L-PROLYL-L-PROLYL-L-SERINAMIDE for Obesity | Overweight
  • Clinical trial in Glioma | Glioblastoma multiforme
  • MELPHALAN for Metastatic breast cancer | Liver-dominant metastatic breast cancer
  • FLUDARABINE PHOSPHATE for B-cell acute lymphoblastic leukemia
  • LENADOGENE NOLPARVOVEC for Leber hereditary optic neuropathy (ND4 mutation)
  • Clinical trial in Relapsed and refractory acute myeloid leukaemia (AML)|Myelodysplastic syndrome (MDS)
  • SODIUM BUTYRATE for Hirschsprung's disease|Congenital megacolon